Nano-X Imaging (NASDAQ:NNOX) Given Buy Rating at D. Boral Capital

D. Boral Capital reaffirmed their buy rating on shares of Nano-X Imaging (NASDAQ:NNOX) in a research report report published on Tuesday,Benzinga reports. They currently have a $5.00 target price on the stock.

Several other research firms also recently weighed in on NNOX. LADENBURG THALM/SH SH upgraded Nano-X Imaging to a “strong-buy” rating in a research report on Thursday, November 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nano-X Imaging in a report on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Nano-X Imaging has a consensus rating of “Buy” and an average price target of $7.00.

Nano-X Imaging Stock Up 5.3%

Shares of Nano-X Imaging stock opened at $2.59 on Tuesday. Nano-X Imaging has a fifty-two week low of $2.11 and a fifty-two week high of $6.42. The business’s fifty day moving average is $2.72 and its two-hundred day moving average is $3.39. The firm has a market cap of $169.33 million, a PE ratio of -1.96 and a beta of 1.38.

Hedge Funds Weigh In On Nano-X Imaging

Hedge funds and other institutional investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Nano-X Imaging by 8.4% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,182 shares of the company’s stock valued at $182,000 after purchasing an additional 2,724 shares during the period. The Manufacturers Life Insurance Company grew its stake in shares of Nano-X Imaging by 20.5% in the second quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock valued at $116,000 after buying an additional 3,818 shares in the last quarter. Russell Investments Group Ltd. grew its stake in shares of Nano-X Imaging by 62.1% in the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock valued at $51,000 after buying an additional 5,283 shares in the last quarter. Gainplan LLC raised its holdings in shares of Nano-X Imaging by 63.1% during the 3rd quarter. Gainplan LLC now owns 18,720 shares of the company’s stock valued at $69,000 after buying an additional 7,239 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in Nano-X Imaging by 64.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock worth $73,000 after acquiring an additional 7,749 shares in the last quarter. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.